193 related articles for article (PubMed ID: 35930300)
1. A Nutritional Blend Suppresses the Inflammatory Response from Bronchial Epithelial Cells Induced by SARS-CoV-2.
Mateus-Silva JR; Oliveira CR; Brandao-Rangel MAR; Silva-Reis A; Olimpio FRDS; Zamarioli LDS; Aimbire F; Vieira RP
J Diet Suppl; 2023; 20(2):156-170. PubMed ID: 35930300
[TBL] [Abstract][Full Text] [Related]
2. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
[TBL] [Abstract][Full Text] [Related]
3. Expression of the SARS-CoV-2 Receptor ACE2 and Proinflammatory Cytokines Induced by the Periodontopathic Bacterium
Takahashi Y; Watanabe N; Kamio N; Yokoe S; Suzuki R; Sato S; Iinuma T; Imai K
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572938
[TBL] [Abstract][Full Text] [Related]
4. Chronic alcohol use primes bronchial cells for altered inflammatory response and barrier dysfunction during SARS-CoV-2 infection.
Easley KF; Edenfield RC; Lott MEJ; Reed RC; Das Sarma J; Mehta AJ; Staitieh BS; Lipp EK; Cho IK; Johnson SK; Jones CA; Bebin-Blackwell AG; Levy JM; Tompkins SM; Easley CA; Koval M
Am J Physiol Lung Cell Mol Physiol; 2023 Nov; 325(5):L647-L661. PubMed ID: 37786945
[TBL] [Abstract][Full Text] [Related]
5. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Induces Expression of Cytokine and MUC5AC/5B in Human Nasal Epithelial Cell through ACE 2 Receptor.
Lee S; Na HG; Choi YS; Bae CH; Song SY; Kim YD
Biomed Res Int; 2022; 2022():2743046. PubMed ID: 35692597
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Infection of Microglia Elicits Proinflammatory Activation and Apoptotic Cell Death.
Jeong GU; Lyu J; Kim KD; Chung YC; Yoon GY; Lee S; Hwang I; Shin WH; Ko J; Lee JY; Kwon YC
Microbiol Spectr; 2022 Jun; 10(3):e0109122. PubMed ID: 35510852
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
[TBL] [Abstract][Full Text] [Related]
9. PM10 promotes an inflammatory cytokine response that may impact SARS-CoV-2 replication
Marín-Palma D; Tabares-Guevara JH; Zapata-Cardona MI; Zapata-Builes W; Taborda N; Rugeles MT; Hernandez JC
Front Immunol; 2023; 14():1161135. PubMed ID: 37180105
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of oxidative stress and inflammation in subjects with COVID-19: Characterization and prognosis of the disease.
Coronel PMV; Pereira IC; Basilio DCLS; Espinoça IT; de Souza KFS; Ota RSN; de Almeida EB; Paredes-Gamero EJ; Wilhelm Filho D; Perdomo RT; Parisotto EB
Microb Pathog; 2023 Nov; 184():106339. PubMed ID: 37690769
[TBL] [Abstract][Full Text] [Related]
11. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment.
Lau SKP; Lau CCY; Chan KH; Li CPY; Chen H; Jin DY; Chan JFW; Woo PCY; Yuen KY
J Gen Virol; 2013 Dec; 94(Pt 12):2679-2690. PubMed ID: 24077366
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis.
Evangelou K; Veroutis D; Paschalaki K; Foukas PG; Lagopati N; Dimitriou M; Papaspyropoulos A; Konda B; Hazapis O; Polyzou A; Havaki S; Kotsinas A; Kittas C; Tzioufas AG; de Leval L; Vassilakos D; Tsiodras S; Stripp BR; Papantonis A; Blandino G; Karakasiliotis I; Barnes PJ; Gorgoulis VG
Eur Respir J; 2022 Aug; 60(2):. PubMed ID: 35086840
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane inhibits the expression of interleukin-6 and interleukin-8 induced in bronchial epithelial IB3-1 cells by exposure to the SARS-CoV-2 Spike protein.
Gasparello J; D'Aversa E; Papi C; Gambari L; Grigolo B; Borgatti M; Finotti A; Gambari R
Phytomedicine; 2021 Jul; 87():153583. PubMed ID: 34033999
[TBL] [Abstract][Full Text] [Related]
14. Distinct Effects of Respiratory Viral Infection Models on miR-149-5p, IL-6 and p63 Expression in BEAS-2B and A549 Epithelial Cells.
Shahdab N; Ward C; Hansbro PM; Cummings S; Young JS; Moheimani F
Cells; 2024 May; 13(11):. PubMed ID: 38891051
[TBL] [Abstract][Full Text] [Related]
15. Lidocaine reinforces the anti-inflammatory action of dexamethasone on myeloid and epithelial cells activated by inflammatory cytokines or SARS-CoV-2 infection.
Elizagaray ML; Mazitelli I; Pontoriero A; Baumeister E; Docena G; Raimondi C; Correger E; Rumbo M
Biomed J; 2023 Feb; 46(1):81-92. PubMed ID: 35948250
[TBL] [Abstract][Full Text] [Related]
16. The Type 2 Asthma Mediator IL-13 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection of Bronchial Epithelium.
Bonser LR; Eckalbar WL; Rodriguez L; Shen J; Koh KD; Ghias K; Zlock LT; Christenson S; Woodruff PG; Finkbeiner WE; Erle DJ
Am J Respir Cell Mol Biol; 2022 Apr; 66(4):391-401. PubMed ID: 34982656
[TBL] [Abstract][Full Text] [Related]
17. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein S1 Induces Methylglyoxal-Derived Hydroimidazolone/Receptor for Advanced Glycation End Products (MG-H1/RAGE) Activation to Promote Inflammation in Human Bronchial BEAS-2B Cells.
Manfredelli D; Pariano M; Costantini C; Graziani A; Bozza S; Romani L; Puccetti P; Talesa VN; Antognelli C
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834316
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of the pro-inflammatory cytokine signature in severe COVID-19.
Hawerkamp HC; Dyer AH; Patil ND; McElheron M; O'Dowd N; O'Doherty L; Mhaonaigh AU; George AM; O'Halloran AM; Reddy C; Kenny RA; Little MA; Martin-Loeches I; Bergin C; Kennelly SP; Donnelly SC; Bourke NM; Long A; Sui J; Doherty DG; Conlon N; Cheallaigh CN; Fallon PG
Front Immunol; 2023; 14():1170012. PubMed ID: 37063871
[TBL] [Abstract][Full Text] [Related]
19. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies.
Conti P; Ronconi G; Caraffa A; Gallenga CE; Ross R; Frydas I; Kritas SK
J Biol Regul Homeost Agents; 2020 March-April,; 34(2):327-331. PubMed ID: 32171193
[TBL] [Abstract][Full Text] [Related]
20. An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2.
Barnett KC; Xie Y; Asakura T; Song D; Liang K; Taft-Benz SA; Guo H; Yang S; Okuda K; Gilmore RC; Loome JF; Oguin Iii TH; Sempowski GD; Randell SH; Heise MT; Lei YL; Boucher RC; Ting JP
Cell Host Microbe; 2023 Feb; 31(2):243-259.e6. PubMed ID: 36563691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
